Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 4335 clinical trials
Prehabilitation for Gastrectomy

Prehabilitation has been demonstrated to be an effective strategy to improve outcomes in patients undergoing some of the abdominal operations. It may increase the physical capacity of the patient, improve postoperative quality of life and even decrease the postoperative morbidity. Currently, the most effective strategy seems to be a trimodal …

gastric cancer
gastrectomy
cancer
  • 0 views
  • 19 Feb, 2024
  • 2 locations
Radical Radiotherapy and Chemotherapy Combined With Maintenance Chemotherapy in the Treatment of Stage N3 NPC

This study is a randomized, phase II, prospective, multicenter clinical trial to evaluate the efficacy and safety of radical chemoradiotherapy plus oral capecitabine/teggio for 1 year in patients with N3.

nasopharyngeal biopsy
nasopharyngeal carcinoma
capecitabine
chemoradiotherapy
alt/ast
  • 0 views
  • 19 Feb, 2024
  • 1 location
Bintrafusp Alfa in Previously Treated Patients With Recurrent and Metastatic (R/M) Non-keratinizing Nasopharyngeal Carcinoma (NPC)

This would be a phase II prospective single arm mono-institutional study conducted in Queen Mary Hospital (Hong Kong) assessing the efficacy and safety of bintrafusp alfa in previously treated patients with recurrent and metastatic (R/M) non-keratinizing nasopharyngeal carcinoma (NPC).

adjuvant
platelet count
carcinoma
infectious mononucleosis
serum bilirubin level
  • 0 views
  • 19 Feb, 2024
  • 1 location
A Study of Hydroxychloroquine vs Placebo to Prevent COVID-19 Infection in Patients Receiving Radiotherapy

The researchers are doing this study to find out whether the study drug hydroxychloroquine can prevent infection with the COVID-19 virus, compared with placebo, in people who are receiving radiation therapy for their cancer. The placebo used in this study is a tablet that looks the same as the study …

chills
sore throat
cancer
acute respiratory syndrome (sars)
throat
  • 0 views
  • 19 Feb, 2024
  • 7 locations
Restrictive Use of Dexamethasone in Glioblastoma

Despite these findings, the suspicion of GBM often triggers the administration of DEX in routine clinical practice, regardless of neurological symptoms, tumor size, or extension of cerebral edema. The purpose of this study is to assess whether selected GBM patients can be treated safely with a restrictive DEX regimen from …

immunosuppression
glioblastoma multiforme
dexamethasone
neurologic symptoms
  • 0 views
  • 19 Feb, 2024
  • 1 location
AIM1: Adequate Selection of Patients for Thyroid Biopsy: Evaluation of a Shared Decision Making Conversation Aid

The study aims to update a conversation aid prototype that was developed to support shared decision making in the diagnosis of thyroid cancer.

aim1
thyroid nodule
thyroid biopsy
cancer
  • 0 views
  • 19 Feb, 2024
  • 2 locations
Bioequivalence and the Tolerability and Antitumor Activity of Selinexor Combination Treatment

During the Combination Therapy Period, the safety and preliminary anti-tumor activity of selinexor in combination with docetaxel (for patients with NSCLC) or pembrolizumab (for patients with CRC) will be evaluated.

adjuvant
monoclonal antibody therapy
drug test
pembrolizumab
carcinoma
  • 0 views
  • 19 Feb, 2024
  • 3 locations
Pilot Study of the Haymakers for Hope Fitness Program

This research study is assessing the effect of an exercise program on cancer survivors. The exercise program is Haymakers for Hope 16-week exercise program

neuropathy
metastasis
cancer
peripheral neuropathy
myocardial infarction
  • 0 views
  • 19 Feb, 2024
  • 1 location
A Study of H3B-6545 in Combination With Palbociclib in Women With Advanced or Metastatic Estrogen Receptor-Positive Human Epidermal Growth Factor Receptor-2 (HER2)-Negative Breast Cancer

The primary objective of this study is to evaluate the safety and tolerability of H3B-6545 and palbociclib when administered in combination in order to determine the maximum tolerated dose (MTD) and/or the recommended Phase 2 dose (RP2D) of this combination in women with advanced or metastatic estrogen receptor-positive (ER+) HER2- …

cancer
estrogen receptor
palbociclib
growth factor
epidermal growth factor receptor
  • 0 views
  • 19 Feb, 2024
  • 7 locations
A Study of Sacituzumab Govitecan (IMMU-132) in Endometrial Carcinoma

This is a non-randomized Phase 2 study of sacituzumab govitecan (IMMU-132) in subjects with persistent or recurrent endometrial carcinoma.

hair thinning
x rays
imaging techniques
cancer
corticosteroids
  • 0 views
  • 19 Feb, 2024
  • 1 location